Literature DB >> 3419477

Measurement of the false positive rate in a screening program for human immunodeficiency virus infections.

D S Burke1, J F Brundage, R R Redfield, J J Damato, C A Schable, P Putman, R Visintine, H I Kim.   

Abstract

In a program screening civilian applicants for U.S. military service for human immunodeficiency virus (HIV) infection, we studied the frequency of false positive diagnoses retrospectively among applicants seropositive for HIV in a subpopulation with a very low prevalence of infection. That subpopulation was defined as consisting of all applicants tested between October 16, 1985, and June 30, 1987, who were young (17 or 18 years of age) and resided in a rural county in a state with a low incidence of reported acquired immunodeficiency syndrome (n = 135,187). Serum specimens from 15 applicants positive for HIV in this low-prevalence subpopulation were retrieved from a serum bank and retested by two Western blot methods, radioimmunoprecipitation, and an immunoassay constructed from a molecularly cloned and expressed viral envelope polypeptide. Fourteen of the 15 samples were unequivocally positive on all retest assays, and 1 was negative. Thus, the measured rate of false positive diagnoses in this program was 1 in 135,187 persons tested. Factors important in achieving a low false positive rate were redundant, multistep testing algorithm, conservative criteria for interpreting Western blots, the requirement that a second, newly drawn serum specimen be tested for verification before a diagnosis of HIV was considered established, and tight quality control of laboratory testing procedures. We conclude that a screening program for HIV infection in a low-prevalence population can have an acceptably low false positive rate.

Entities:  

Mesh:

Year:  1988        PMID: 3419477     DOI: 10.1056/NEJM198810133191501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  29 in total

1.  Evaluation of a line immunoassay for the differential detection of antibodies to human immunodeficiency virus.

Authors:  R Vranckx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

2.  Five cases of erroneously diagnosed HIV infection.

Authors:  M J Gill; A Rachlis; C Anand
Journal:  CMAJ       Date:  1991-12-15       Impact factor: 8.262

3.  Point-of-care testing for HIV: HIV counselling and testing.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis       Date:  2002-03

4.  Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1.

Authors:  A J Whetsell; J B Drew; G Milman; R Hoff; E A Dragon; K Adler; J Hui; P Otto; P Gupta; H Farzadegan
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

5.  Predicting human immunodeficiency virus type 1-positive sera by using two enzyme immunoassay kits in a parallel testing format.

Authors:  K Fonseca; C M Anand
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

6.  Evaluation of a human immunodeficiency virus test algorithm utilizing a recombinant protein enzyme immunoassay.

Authors:  D G Lepine; P W Neumann; S L Frenette; M V O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  The case against HIV antibody testing of refugees and immigrants.

Authors:  J E Parker
Journal:  CMAJ       Date:  1990-03-15       Impact factor: 8.262

8.  Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada.

Authors:  L Samson; S King
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

9.  Inpatient morbidity among HIV-infected male soldiers prior to their diagnosis of HIV infection.

Authors:  P O Renzullo; J G McNeil; L I Gardner; J F Brundage
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

10.  Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology.

Authors:  B Forghani; J W Hurst; C S Chan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.